(Q37607920)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19801562%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

review article

1 reference

title

Introducing a new entity: chemotherapy-induced arrhythmia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19801562%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19801562%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

author name string

Mohsen Aljayeh

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19801562%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Saleemuddin Saiyad

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19801562%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Rias Ali

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19801562%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Anne B Curtis

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19801562%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

publication date

3 October 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19801562%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19801562%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19801562%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19801562%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

page(s)

1579-1586

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19801562%20AND%20SRC:MED&resulttype=core&format=json

The prevention and management of cardiovascular complications of chemotherapy in patients with cancer

9 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP300

Esmolol is antiarrhythmic in doxorubicin-induced arrhythmia in cultured cardiomyocytes - determination by novel rapid cardiomyocyte assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP300

The effects of adriamycin on normal and ouabain-toxic canine Purkinje and ventricular muscle fibers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP300

Electrocardiographic changes following adriamycin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP300

Docetaxel with epirubicin--investigations on cardiac safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP300

Early and late arrhythmogenic effects of doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP300

Doxorubicin-induced second degree and complete atrioventricular block

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP300

Atrial fibrillation following chemotherapy for stage IIIE diffuse large B-cell gastric lymphoma in a patient with myotonic dystrophy (Steinert's disease).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP300

Left ventricular diastolic performance in breast cancer survivors treated with anthracyclines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP300

Doxorubicin-induced ventricular arrhythmia treated by implantation of an automatic cardioverter-defibrillator.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP300

Cardiotoxicity of the antiproliferative compound fluorouracil

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP300

A new perspective on cardiotoxicity of 5-fluorouracil. A novel research tool 'cardiac ultrasonic integrated backscatter analysis' indicates transient, subclinical myocardial dysfunction due to high-dose leucovorin and infusional 5-fluorouracil regim

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP300

Supraventricular arrhythmia: a complication of 5-fluorouracil therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP300

Influence of high-dose leucovorin and 5-fluorouracil chemotherapy regimen on P wave duration and dispersion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP300

Transient asymptomatic bradycardia in patients on infusional 5-fluorouracil

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP300

Adverse cardiac effects during induction chemotherapy treatment with cis-platin and 5-fluorouracil

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP300

Clinical cardiotoxicity of 5-fluorouracil

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP300

The frequency and pattern of cardiotoxicity observed with capecitabine used in conjunction with oxaliplatin in patients treated for advanced colorectal cancer (CRC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP300

Gemcitabine-induced atrial fibrillation: a hitherto unreported manifestation of drug toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP300

Atrial fibrillation induced by gemcitabine treatment in a 65-year-old man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP300

Activity and toxicity of gemcitabine and gemcitabine + vinorelbine in advanced non-small-cell lung cancer elderly patients: Phase II data from the Multicenter Italian Lung Cancer in the Elderly Study (MILES) randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP300

Severe non-haematological toxicity after treatment with gemcitabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP300

Phase I-II trial of low-dose gemcitabine in prolonged infusion and cisplatin for advanced non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP300

Gemcitabine and atrial fibrillation: a rare manifestation of chemotherapy toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP300

The cyclin-dependent kinase inhibitor UCN-01 plus cisplatin in advanced solid tumors: a California cancer consortium phase I pharmacokinetic and molecular correlative trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP300

Phase I to II study of pleurectomy/decortication and intraoperative intracavitary hyperthermic cisplatin lavage for mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP300

Melphalan 220 mg/m2 followed by peripheral blood stem cell transplantation in 27 patients with advanced multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP300

Amifostine and autologous hematopoietic stem cell support of escalating-dose melphalan: a phase I study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP300

Paroxysmal atrial fibrillation after high-dose melphalan in five patients autotransplanted with blood progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP300

The role of autologous transplantation in patients with multiple myeloma aged 65 years and over

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP300

Cardiac effects within 3 months of BEAC high-dose therapy in non-Hodgkin's lymphoma patients undergoing autologous stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP300

Very acute cardiac toxicity during BEAC chemotherapy in non-Hodgkin's lymphoma patients undergoing autologous stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP300

High-dose cyclophosphamide and MESNA infusion can cause acute atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP300

Recurrent atrial ectopic tachycardia following chemotherapy with ifosfamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP300

High-dose ifosfamide is associated with severe, reversible cardiac dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP300

Increased cardiotoxicity of sorafenib in sunitinib-pretreated patients with metastatic renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP300

Cardiac toxicity of alemtuzumab in patients with mycosis fungoides/Sézary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP300

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP300

Prolongation of cardiac repolarization by arsenic trioxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP300

Cardiac monitoring of patients receiving arsenic trioxide therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP300

Effect of Arsenic Trioxide on QT Interval in Patients With Advanced Malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP300

Two cases of acute promyelocytic leukemia complicated by torsade de pointes during arsenic trioxide therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP300

Torsades de pointes in 3 patients with leukemia treated with arsenic trioxide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP300

21 January 2018

Thalidomide in cancer

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP300

Thalidomide as initial therapy for early-stage myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP300

Sustained ventricular tachycardia in a thalidomide-treated patient with primary plasma-cell leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP300

Low-dose interleukin-11 in patients with bone marrow failure: update of the M. D. Anderson Cancer Center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP300

21 January 2018

Identifiers

DOI

10.1093/EUROPACE/EUP300

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19801562%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference